Claims
- 1. A combination comprising:
(a) at least one opioid; and (b) at least one synthetic superoxide dismutase catalyst.
- 2. A combination according to claim 1, wherein the combination is capable of treating, preventing, reversing or inhibiting pain or inflammation when administered to a patient in need thereof.
- 3. A combination according to claim 2, wherein the combination is capable of producing an additive or synergistic antihyperalgesia or antinociception effect in the patient after administering the combination.
- 4. A combination according to claim 3, wherein the opioid of the combination comprises at least about 50% less than the same opioid administered alone to achieve the antihyperalgesia or antinociception effect.
- 5. A combination according to claim 4, wherein the opioid of the combination comprises at least about 25% less than the same opioid administered alone to achieve the antihyperalgesia or antinociception effect.
- 6. A combination according to claim 5, wherein the opioid of the combination comprises at least about 10% less than the same opioid administered alone to achieve the antihyperalgesia or antinociception effect.
- 7. A combination according to claim 6, wherein the opioid of the combination comprises at least about 1% less than the same opioid administered alone to achieve the antihyperalgesia or antinociception effect.
- 8. A combination according to claim 2, wherein the opioid and the synthetic superoxide dismutase catalyst are combined prior to administration to the patient.
- 9. A combination according to claim 2, wherein the opioid and the synthetic superoxide dismutase catalyst are combined upon administration to the patient.
- 10. A combination according to claim 1, wherein the opioid is selected from the group consisting of morphine, oxycontin, oxycodone, codeine, fentanyl and any combination thereof.
- 11. A combination according to claim 1, wherein the synthetic superoxide dismutase catalyst is represented by the formula:
- 12. A combination according to claim 11, wherein the synthetic superoxide dismutase catalyst is represented by the formula:
- 13. A combination according to claim 11, wherein the synthetic superoxide dismutase catalyst is represented by the formula:
- 14. A combination according to claim 11, wherein the synthetic superoxide dismutase catalyst is represented by the formula:
- 15. A compound of the formula An-Qm, wherein A is a superoxide dismutase catalyst moiety, Q is an opioid moiety, and n and m are independently integers from 1 to 3.
- 16. A compound according to claim 15, wherein the opioid moiety is selected from the group consisting of morphine, oxycontin, oxycodone, codeine, fentanyl and any combination thereof.
- 17. A compound according to claim 15, wherein the synthetic superoxide dismutase catalyst moiety is represented by the formula:
- 18. A compound according to claim 17, wherein the synthetic superoxide dismutase catalyst is represented by the formula:
- 19. A compound according to claim 17, wherein the synthetic superoxide dismutase catalyst is represented by the formula:
- 20. A compound according to claim 17, wherein the synthetic superoxide dismutase catalyst is represented by the formula:
CROSS-REFERENCES TO RELATED APPLICATIONS
[0001] This application is a continuation of co-pending U.S. application Ser. No. 09/997,974 filed Nov. 30, 2001 which is a continuation-in-part of U.S. application Ser. No. 09/634,152 filed Aug. 9, 2000, now U.S. Pat. No. 6,395,725, which is a divisional of U.S. application Ser. No. 09/057,831 filed April 9,1998, now U.S. Pat. No. 6,180,620, which claimed the benefit of U.S. Provisional Application No. 60/050,402 filed Jun. 20, 1997. Each patent and patent application above is incorporated herein by reference in its entirety.
[0002] Not Applicable.
[0003] Not Applicable.
Provisional Applications (1)
|
Number |
Date |
Country |
|
60050402 |
Jun 1997 |
US |
Divisions (1)
|
Number |
Date |
Country |
Parent |
09057831 |
Apr 1998 |
US |
Child |
09634152 |
Aug 2000 |
US |
Continuations (1)
|
Number |
Date |
Country |
Parent |
09997974 |
Nov 2001 |
US |
Child |
10738578 |
Dec 2003 |
US |
Continuation in Parts (1)
|
Number |
Date |
Country |
Parent |
09634152 |
Aug 2000 |
US |
Child |
09997974 |
Nov 2001 |
US |